8-K: Adia Nutrition Becomes Adia Med, Inc.

Adia Nutrition, Inc. has officially changed its corporate name to Adia Med, Inc., with the change effective June 2, 2026, and FINRA approval received on July 10, 2026.

Summary

• Adia Nutrition, Inc. has officially changed its corporate name to Adia Med, Inc.
• The name change was effective on June 2, 2026, with the filing of a Certificate of Amendment with the Secretary of State of Nevada.
• The company's board of directors also filed a Certificate of Amendment to reflect the new name in the Articles of Incorporation.
• FINRA provided final approval for the name change on July 10, 2026.
• The company elected to file this Form 8-K after its quarterly report for the period ending June 30, 2026, to avoid potential Edgar system issues.
• All future filings will be under the new name, Adia Med, Inc.
• The company's common stock will continue to trade under the ticker symbol ADIA on the OTC Markets Venture Markets.
• Existing stock certificates remain valid and do not require exchange.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development, primarily due to the successful corporate name change and the clear communication regarding its implications. The filing indicates operational continuity and regulatory compliance.

Positives

• Successful completion of corporate name change from Adia Nutrition, Inc. to Adia Med, Inc.
• Official effective date of name change established as June 2, 2026.
• Regulatory approval from FINRA received on July 10, 2026, confirming the name change.
• Clear communication that existing stock certificates remain valid, avoiding shareholder confusion or administrative burden.
• Assurance that the company's common stock will continue trading under the existing ticker symbol ADIA.

Future Outlook

All future reports will be filed under the new name, Adia Med, Inc. The company's common stock will continue to trade under the ticker symbol ADIA on the OTC Markets Venture Markets.

Management Comments

• The Company elected to file this Form 8-K after the successful filing of its quarterly report for the three and six months ended June 30, 2026, in order to avoid any potential impacts to the timely filing of its Form 10-Q due to changes necessitated in the Edgar system.

Industry Context

StockSavvy.ai notes that corporate name changes are common, especially when a company pivots its strategic focus or seeks to better align its brand with its evolving business operations. The transition to 'Adia Med, Inc.' suggests a potential shift or emphasis towards the medical or healthcare sector.

Corporate Governance

Stakeholder Impact

• Shareholders: No impact expected on existing stock certificates; trading continues under the same ticker symbol.
• Regulatory Bodies (e.g., FINRA, SEC): Compliance with filing requirements for name change achieved.
• General Public/Customers: Potential perception shift due to the name change to 'Adia Med, Inc.', suggesting a focus on the medical sector.

Next Steps

• File all future reports under the new name, Adia Med, Inc.
• Continue trading common stock under the ticker symbol ADIA on the OTC Markets Venture Markets.

Key Dates

Keywords

corporate name change, Adia Med, Adia Nutrition, Nevada, FINRA approval, Articles of Incorporation, OTC Markets